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1. Introduction
   Tissue hypoxia and reoxygenation (HR) remain one of 
the main causes of permanent or transient damage with 
serious implications on adjacent organs and certainly on 
patients’ health. The use of antioxidant substances has 
been a research subject for many years. However, even if 
important progress has been made, satisfactory answers 
have not been given yet to fundamental questions, such as, 
how much powerful should an antioxidant be, when should 
it be administered, and in which dosage. The particularly 
satisfactory action of the antioxidant U-74389G in tissue 
protection has been noted in several performed experiments. 
Since a careful literature search (PubMed - Medline) was 
conducted, it was realized that this certain antioxidant 
has been tried in ischemia reperfusion (IR) experiments. 
However, just few relative reports were found, not covering 
completely this particular matter. Also, a lot of publications 
addressed trials of other similar molecules of aminosteroids 
(lazaroids) to which the studied molecule also belongs 
to. U-74389G or better 21-[4-(2,6-di-1-pyrrolidinyl-4-
pyrimidinyl)-1-piperazinyl]-pregna-1,4,9(11)-triene-
3,20-dione maleate salt1 is an antioxidant which prevents 
both arachidonic acid-induced and iron-dependent lipid 
peroxidation. It protects against HR injury in animal heart, 
liver, and kidney models. These membrane-associating 
antioxidants2 are particularly effective in preventing 
permeability changes in brain microvascular endothelial 
cells monolayers. The same authors3-6 found the influence 
of U-74389G as depicted at table 1.1 on some biochemic 
variables serum levels in related IR injury experiments 
in rats 1 h, 1.5 h, 2 h and interaction of U-74389G and 
reperfusion time after reperfusion (Table 1).
  The aim of this experimental study was to examine the 
effect of the antioxidant drug “U-74389G” on rat model and 
Objective: To examine the effect of the antioxidant drug “U-74389G”, on rat model and 
particularly in a hypoxia reoxygenation (HR) protocol. The beneficial effect or non-effectiveness 
of that molecule was studied hematologically using mean red blood cells levels. Methods: 40 
rats of mean weight 231.875 g were used in the study. Red blood cells levels were measured 60 
min after reoxygenation (groups A and C) and 120 min after reoxygenation (groups B and D) with 
administration of the drug U-74389G only in groups C and D. Results: U-74389G administration 
non-significantly increased the red blood cells level by (0.64依0.32)% (P=0.810 6). Reoxygenation 
time also non-significantly increased the red blood cells level by (4.63依2.36)% (P=0.068 0). 
However, U-74389G administration and reoxygenation time together non-significantly increased 
the red blood cells level by (1.05依0.53)% (P=0.491 1). Conclusions: Results of this study show that 
U-74389G administration, reoxygenation time and their interaction non significantly increased 
the red blood cells levels within 2 hours’ time interval.   
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particularly in a HR protocol. The beneficial effect or non-
effectiveness of that molecule was studied by measuring the 
red blood cells (RBC) levels.  
2. Materials and methods
2.1. Animal preparation
  This experimental study was laid out at the Exprerimental 
Research Center of ELPEN Pharmaceuticals Co. Inc. 
S.A. at Pikermi, Attiki and by Veterinary Address of East 
Attiki Prefecture under 3693/12-11-2010 & 14/10-1-2012 
decisions. All settings needed for the study including of 
consumables, equipment and substances used, were a 
courtesy of that S. A. Albino female Wistar rats were used 
in accordance with accepted standards of humane animal 
care. They spent in laboratory 7 days before the experiment 
with easy access to water and food. The experiment 
was acute, that is, the animal usage was completed by 
following experimental set of times without awakening and 
preservation of the rodents. They were randomly assigned to 
four experimental groups (10 animals in each group). 
  1) Hypoxia for 45 min followed by reoxygenation for 60 min 
(group A). 
  2) Hypoxia for 45 min followed by reoxygenation for 120 
min (group B). 
  3) Hypoxia for 45 min followed by immediate U-74389G 
intravenous (IV) administration and reoxygenation for 60 min 
(group C). 
  4) Hypoxia for 45 min followed by immediate U-74389G IV 
administration and reoxygenation for 120 min (group D). 
  The molecule U-74389G dose was 10 mg/kg body weight 
of animals. The experiment started with prenarcosis. Then, 
animals were submitted into general anesthesia. Their 
electrocardiogram and acidometry were continuously 
monitored. The inferior aorta was prepared so as its flow 
to be excluded by forceps. After exclusion, the protocol 
of HR was applied, exactly as described in experimental 
groups. The molecules were administered at the time 
of reoxygenation, through inferior vena cava after 
catheterization achieved after general anesthesia. The RBC 
measurement was performed at 60 min of reoxygenation 
(groups A and C) and 120 min of reoxygenation (groups B and 
D). 
  Rats were submitted into general anesthesia by initial 
intramuscular (IM) administration of 0.5 cc compound, 
which constituted of 0.25 cc xylazine, [25 cc, 20 mg/cc] and 
0.25 cc ketamine hydrochloride [1 000, 100 mg/cc, 10 cc]. 
Before initiation of laparotomy, 0.03 cc butorphanol [10 mg/
cc, 10 cc] anesthetic agent was administered subcutaneous 
(SC). Continuous oxygen supply was administered during 
whole experiment performance. Ischemia was caused by 
clamping inferior aorta, over renal arteries, for 45 min 
after laparotomic access was achieved. Reoxygenation was 
induced by removing the clamp and reestablishment of 
inferior aorta patency. Forty (40) female Wistar albino rats 
were used of mean weight 231.875 g [Std. Dev: 36.597 03 
g], with min weight ≥ 165 g and max weight < 320 g. Rats 
weight could be potentially a confusing factor, e.g. fatter 
rats to have greater RBC levels. This suspicion will be 
investigated.
2.2. Model of hypoxia reoxygenation injury
  Control groups: 20 control rats of mean weight 252.5 g 
[Std. Dev: 39.319 88 g] were subjected to hypoxia for 45 min 
followed by reoxygenation.
  Group A: Reoxygenation which lasted 60 min concerned 
10 controls rats of mean weight 243 g [Std. Dev: 45.777 24 g], 
mean RBC levels 6.983 106/mm3 [Std. Dev: 0.583 629 4 106/
mm3] (Table 2).    
Table 2.
Weight and RBC mean values and Std. Dev. of groups.
Groups Weight (g) RBC (×106/mm3)
 Mean Std. Dev  Mean Std. Dev
A 243.0 45.777 24 6.983 0.583 629 4
B 262.0 31.109 13 7.362 0.648 344 9
C 212.5 17.834 11 7.081 0.508 056 2
D 210.0 18.104 63 7.354 0.442 422 6
  Group B: Reoxygenation which lasted 120 min concerned 
10 controls rats of mean weight 262 g [Std. Dev: 31.109 13 g], 
mean RBC levels 7.362 106/mm3 [Std. Dev: 0.648 344 9 106/
mm3] (Table 2).          
  Lazaroid (L) group: 20 rats of mean weight 211.25 g [Std. 
Dev: 17.537 55 g] suffered by hypoxia for 45 min followed by 
reoxygenation in the beginning of which 10 mg U-74389G/kg 
Table 1. 
The U-74389G influence (+SD) on the levels of some biochemic variables concerning reperfusion (rep) time.
Variable 1.0 h rep P-value 1.5 h rep P-value 2.0 h rep P-value Interaction of U-74389G 
and rep
P-value
Alkaline phosphatase   (22.66依12.37)% 0.066 3 (31.91%依7.69)% 0.000 1 (41.16依9.65)% 0.000 3 (17.75依4.79)% 0.000 5 
sodium   (1.22依0.66)% 0.070 7   (0.17%依0.61)% 0.771 4 (-0.87依1.03)% 0.399 5 (-0.32依0.36)% 0.369 3 
chloride (-0.58依0.77)% 0.453 3 (-0.97%依0.53)% 0.087 9 (-1.36依0.76)% 0.111 3 (-0.75依0.38)% 0.015 9 
phosphorus (-2.23依5.51)% 0.796 6 (-1.61%依3.32)% 0.578 9 (-1.00依4.48)% 0.812 9 (-1.09依2.00)% 0.577 1
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body weight were IV administered. 
  Group C: Reoxygenation which lasted 60 min concerned 10 
L rats of mean weight 212.5 g [Std. Dev: 17.834 11 g], mean 
RBC levels 7.081 106/mm3 [Std. Dev: 0.508 056 2 106/mm3] 
(Table 2).  
  Group D: Reoxygenation which lasted 120 min concerned 
10 L rats of mean weight 210 gr [Std. Dev: 18.104 63 g], mean 
RBC levels 7.354 106/mm3 [Std. Dev: 0.442 422 6 106/mm3] 
(Table 2). 
3. Results
  Every weight rats group initially was compared with each 
one from 3 remained groups applying statistical paired 
t-test (Table 3). Any emerging significant difference among 
RBC levels will be investigated whether owed in the above 
probable mentioned significant weight correlations. Every 
RBC levels rats group initially was compared with each one 
from 3 remained groups applying statistical paired t-test 
(Table 3). 
Table 3.
Statistical significance of mean values difference for groups (DG) after 
statistical paired t test application. 
DG Weight (g) RBC (×106/mm3)
Difference P-value Difference P-value
A-B -19.0 0.242 3 -0.378 999 9 0.214 4
A-C 30.5 0.067 4 -0.098 000 1 0.738 8
A-D 33.0 0.057 4 -0.371 000 1 0.202 2
B-C 49.5 0.001 9 0.280 999 9 0.330 6
B-D 52.0 0.000 4 0.007 999 8 0.977 8
C-D 2.5 0.704 3 -0.273  000 0 0.223 9
  Applying generalized linear models (glm) with dependent 
variable the red blood cells levels and independent variables 
the U-74389G administration or no, the reoxygenation time 
and their interaction, resulted in: U-74389G administration 
non significantly increased the red blood cells level by 
0.045 000 1 106/mm3 [-0.315 108 9 106/mm3 - 0.405 109 
2 106/mm3] (P=0.801 7). This finding was in accordance 
with the results of paired t-test (P=0.819 5). Reoxygenation 
time also non-significantly increased the red blood cells 
level by 0.326 106/mm3 [-0.018 144 5 106/mm3 - 0.670 144 
5 106/mm3] (P=0.062 7), in accordance also with paired 
t-test (P=0.073 3). However, U-74389G administration and 
reoxygenation time together non-significantly increased 
the red blood cells level by 0.074 181 9 106/mm3 [-0.141 
785 2 106/mm3 - 0.290 149 106/mm3] (P=0.491 1). Reviewing 
the above and Table 3, Tables 4 and 5 sum up concerning 
the increasing influence of U-74389G in connection with 
reoxygenation time. Inserting the rats weight also as an 
independent variable at generalized linear models analysis, 
a non-significant relation results in red blood cells levels 
(P=0.093 7), so as to further investigation is not needed. 
Table 5. 
The (%) increasing influence of U-74389G in connection with 
reoxygenation time.                                                                                                                
Increase 依SD Reoxygenation time P-values
1.39% 依0.71% 1.0 h 0.716 1
0.64% 依0.32% 1.5 h 0.810 6
-0.10% 依0.05% 2.0 h 0.976 2
4.63% 依2.36% Reoxygenation time 0.068 0
1.05% 依0.53% Interaction 0.491 1
4. Discussion
  Lee CH et al studied[7] Wistar rats after three hours ileal 
IR injury and noticed significant decreases in circulating 
red blood cells levels than control ones. Wang MX et al 
investigated[8] the effect of IR-induced Wistar rat mesenteric 
microcirculatory dysfunctions randomly distributed into 5 
groups. I/R led to circulating red blood cells among all IR-
induced manifestations, significantly reduced in mesenteric 
post-capillary venules. Ghibu S et al studied[9] the effects 
of post-ischemic recovery and oxidative stress in isolated 
perfused rat hearts challenged with an IR sequence. Red 
cells are a good model to investigate oxidative damage in 
biological membranes; lipoic acid induced a slight increase 
in coronary flow in isolated perfused hearts, after global 
total ischemia. Gumuştaş K et al investigated[10] the effects 
of superoxide dismutase (SOD) expression in hyperglycemic 
rats after cerebral ischemia reperfusion injury. Superoxide 
dismutases SOD in red blood cells were detected in 
hyperglycemic rats with cerebral IR injury induced by two 
common carotid artery occlusions. Treatment prophylaxis 
increased SOD in IR. Arumugam TV et al subjected[11] 
female Wistar rats to renal IR. Pre-ischemic treatment with 
the C5a receptor (C5aR) antagonist substantially inhibited 
or prevented IR-induced tissue hemorrhage, hematuria, 
vascular leakage and microvascular permeability. This 
Table 4.
The increasing influence of U-74389G in connection with reperfusion time.
       Increase 95% c. in. Reperfusion time (h)
P-values
t-test glm
0.098 000 10 -0.416 079 8 -0.612 080 0 1.0 0.738 8 0.693 5
0.045 000 15 -0.315 108 9 -0.405 109 2 1.5 0.819 5 0.801 7
-0.007 999 80 -0.529 472 6 -0.513 472 9 2.0 0.977 8 0.974 6
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antagonist, however, did not inhibit complement-mediated 
lysis of red blood cells, suggesting unimpaired formation 
of the membrane attack complex. Bekyarova G et al 
supposed[12] that burns are followed by oxidative changes in 
red blood cells, probably as a result of IR which takes place 
in the microvasculature of rats injured tissues. This leads to 
a marked decrease in erythrocyte deformability, one of the 
most prominent factors for hemorheological disorders in the 
early post-burn period. Decreased erythrocyte deformability 
is partly related with oxidative membrane damage of red 
blood cells in the early post burn period. Lennon GM et al 
applied[13] acute unilateral renal IR to four groups of ten 
adult male Wistar rats.   The vascular perfusion indexes 
(VPI) for each vascular region of the kidney were similar 
in control and ischemic kidneys that were not subjected 
to reflow. In contrast, VPI was markedly decreased in 
the inner stripe and inner medulla in animals in which 
revascularisation had occurred, and the vasculature in these 
regions was histologically shown to be packed with red 
blood cells. Post-ischemic renal failure is associated with 
hyperperfusion (vascular hyperemia) of the medulla (outer 
medulla) resulting from blockage of the vasculature that 
occurs during revascularisation.
  U-74389G also influences the RBC level. Pratt MF 
examined[14] the effects of 21-aminosteroid U-74389G on pig 
model random skin flap survival/necrosis pathophysiology. 
Demonstrated mechanisms of skin flap failure included 
the alteration of erythrocyte flexibility with resultant 
accumulation of damaging oxygen-free radicals. Random 
skin flap survival was improved significantly with U-74389G 
administration.
  U-74389G administration, reoxygenation time and their 
interaction non significantly increase the red blood cells 
level within 2 hours’ time interval. This drug may need 
more time in order to reveal its significant acute increasing 
capacity. Clinical trials with larger samples and longer study 
times may prove it.  
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